Abstract-Cardiovascular diseases are a consequence of genetic and environmental risk factors that together generate arterial wall and cardiac pathologies. Blood vessels connect multiple systems throughout the entire body and allow organs to interact via circulating messengers. These same interactions facilitate nervous and metabolic system's influence on cardiovascular health. Multiparametric imaging offers the opportunity to study these interfacing systems' distinct processes, to quantify their interactions, and to explore how these contribute to cardiovascular disease. Noninvasive multiparametric imaging techniques are emerging tools that can further our understanding of this complex and dynamic interplay. Positron emission tomography/magnetic resonance imaging and multichannel optical imaging are particularly promising because they can simultaneously sample multiple biomarkers. Preclinical multiparametric diagnostics could help discover clinically relevant biomarker combinations pivotal for understanding cardiovascular disease. Interfacing systems important to cardiovascular disease include the immune, nervous, and hematopoietic systems. These systems connect with classical cardiovascular organs, such as the heart and vasculature, and with the brain. The dynamic interplay between these systems and organs enables processes, such as hemostasis, inflammation, angiogenesis, matrix remodeling, metabolism, and fibrosis. As the opportunities provided by imaging expand, mapping interconnected systems will help us decipher the complexity of cardiovascular disease and monitor novel therapeutic strategies. (Circ Cardiovasc Imaging.
C ardiovascular disease affects blood vessels throughout the body and therefore leads to comorbidities in multiple organs. Traditionally, cardiovascular research has focused on vital organs, including the heart or brain after ischemic infarction, and on large vessels with atherosclerotic lesions. Decades of research targeting cardiovascular tissues have built a broad base of knowledge on the cellular and molecular mechanisms underlying atherosclerosis, stroke, and heart failure. At the same time, we increasingly understand that the immune, nervous, and hematopoietic systems influence cardiovascular disease, although many of the mechanisms remain to be uncovered ( Figure 1 ).
Imaging research has often focused on only one biomarker at a time. Recent technological advances have led to multichannel data acquisition that provides multibiomarker information on metabolic, cellular, or molecular processes. A whole new set of questions could be addressed by investigating simultaneously multiple biomarkers during cardiovascular disease. Of particular interest, and now potentially accessible, are the interactions between the molecular and the cellular processes initiating cardiovascular disease. Which organ systems are involved in disease initiation? How do multiple biomarkers interact to promote disease? Does multimodal imaging of several biomarkers increase assay sensitivity and specificity?
In this review, we argue that multiparametric imaging can provide data on system interactions and thus connect traditionally separated fields of investigation. Our review's focus is on the most common appearances of cardiovascular disease, namely atherosclerotic blood vessels leading to myocardial infarction or stroke. We will discuss multichannel optical and hybrid positron emission tomography/magnetic resonance imaging (PET/MRI) because these modalities have evolved rapidly and will provide, in our opinion, the most data-rich insight at both the basic science and the translational levels. More specifically, preclinical optical and PET/MR imaging can provide orthogonal, quantitative data on two or more biomarkers, which, if well chosen, may provide different perspectives on disease pathways. Below we first describe selected imaging approaches' capabilities and advances and then detail how these approaches have been used in multiparametric data acquisition to address complex biological questions. We also discuss how imaging may help uncover interactions between cardiovascular and other organs.
Multichannel Optical Imaging
The most commonly used intravital microscopy techniques for real-time and longitudinal imaging of dynamic processes Multiparametric Imaging of Organ System Interfaces are confocal, 2-photon, or multiphoton microscopy.
1,2 Optical imaging is based on photon detection and allows the simultaneous study of multiple fluorescent proteins with unique, separable wavelengths. To distinguish and follow cells in vivo, molecules or cells have to be labeled. Labeling can be either genetic or chemical. Genetic labeling (of stromal and immune cells, among others) is based on gene expression reporting via a fluorescent protein, such as green or yellow fluorescent protein (GFP or YFP). 3 Chemical labeling via injectable imaging agents includes fluorescently labeled antibodies for surface antigens and fluorescently labeled imaging agents that are taken up by cells, such as macrophages. Labeling with cytosolic or membrane dyes requires adoptive transfer of cells harvested from a donor. Finally, vascular and activatable dyes can visualize the intravascular space and enzymatic activity in tissues. 4, 5 Multiphoton microscopy also detects second harmonic generation signals arising from collagen without exogenous labeling. Second harmonic generation light is emitted at exactly half the wavelength of the exiting photons entering the tissue. 6 Several limitations of intravital microscopy are well recognized. First, the background signal from naturally fluorescent cellular components, also known as autofluorescence, typically lowers the signal-to-background ratio. Second, because intravital microscopy has limited tissue penetration, its imaging depth is always <800 μm and often much less than that. Third, longer excitation of some sensitive fluorescent proteins can render them nonfluorescent, a process called photobleaching. Two-or multiphoton microscopy overcomes these hurdles, and thus has advantages over confocal microscopy because the laser selectively excites a specific focal plane where the 2 photons coincide, thereby allowing deeper imaging with less photobleaching and a lower autofluorescence signal. 7 In addition, newer fluorescent proteins have emission and excitation wavelengths with deeper tissue penetration and increased signal-to-background ratio for more efficient in vivo use. 8, 9 The limited depth penetration of light often necessitates delicate mouse surgery to access organs of interest. It is crucial to avoid damaging the imaged tissue, to keep it at physiological temperature, and to maintain blood flow to the area. For example, the frontoparietal skull is exposed to visualize hematopoietic stem cells (HSCs) in their niche. 10, 11 Exposing the brain by either thinning the skull 12 or a small craniotomy 13 makes it possible to visualize cerebral processes. 14 Organ systems, such as the spleen, 15, 16 liver, 17 or lymph nodes, 18 can be exposed through surgical procedures and windows. Because motion caused by respiration and blood vessel pulses can cause artifacts, accurate imaging requires tissue immobilization and deep anesthesia. In the heart 19 and major arteries, 20 acquisition gating and postprocessing methods used in conjunction with tissue stabilizers have recently overcome motion artifacts ( Figure 2A ). Several new developments have made optical imaging a highly useful research tool. For example, multiphoton microscopy can now detect a larger palette of fluorescent probes in a living mouse.
14 This is particularly interesting when combined with genetic constructs to follow clonal cell populations such as Brainbow in neurons 21 or, more recently, HUe in bone marrow HSCs. 22 These approaches are transgenic strategies to combinatorially express fluorescent proteins that visualize Figure 1 . Immune-cardiovascular hematopoietic, and nervous system interactions forming a circuit in cardiovascular disease. Multiparametric Imaging of Organ System Interfaces synaptic circuits by genetically labeling cells with 90 hues for Brainbow or even, theoretically, >10 3 colors for Hue and then tracking the labeled cells over prolonged space in the organ or temporal periods (weeks or months). 21, 22 In another innovative method, optogenetic tools use genetically modified cells (typically neurons) to express light-sensitive ion channels like channelrhodopsin. This (neuro) modulation method controls cell activity, which can then be optically recorded with the help of optical activity sensors, such as calcium (GCaMP). 23 Calcium imaging has recently been used to map neural activation patterns while mice ran on treadmills. Later, when mice were resting, those neurons reactivated, which suggests mice retrieve memories of earlier exercise. 24 In the heart, voltage and calcium optical mapping has been extensively performed using the Langendorff method. Optogenetic tools have recently been implemented in cardiomyocytes in vivo by optically pacing light-sensitive ion channels. 25 Optical calcium mapping depicted subsequent myocardial activation. 25 In addition, ex vivo optical imaging by confocal and 2-or multiphoton microscopy has made some major advances as tissue clearing has become available. Solvent-based or aqueous-based clearing reduces light scatter's obscuring effects in tissue samples, thereby assuring a low uniform scatter. New reagents, such as aptamers and single-domain antibodies, facilitate immunostaining in thick tissues to produce snapshot views of entire organ systems with microscopic resolution. 26 Deep tissue optical imaging has limited resolution because photon scattering leads to insufficient signal and reduced sensitivity. In vivo optical imaging techniques that can overcome this limitation include optical frequency domain imaging with wide-field imaging, 27 fluorescence-mediated tomography (FMT) in combination with computed tomography (CT), 28 Figure 2. A, Intravital imaging of structure and function in the beating heart at cellular resolution. Reprinted from Vinegoni et al 19 with permission of the publisher. Copyright ©2015, Nature Publishing Group. B, Serial intravital microscopy of increased hematopoietic stem cells (HSC), sorted and labeled ex vivo with DiD (1,1′-dioctadecyl-3,3,3′,3′-tetramethylindodicarbocyanine perchlorate) fluorescent dye, reporting on their expansion in the bone marrow of mice with stroke. Serial intravital microscopy of the mouse calvarium 1 day before and 3 days after transient middle cerebral artery occlusion (tMCAO). Blue color represents the fluorescence signal produced by the bone imaging agent OsteoSense-750; the fluorescence lectin signal stained blood vessels in red. DiD-labeled HSC are shown in white. Reprinted from Courties et al 5 with permission of the publisher. Copyright ©2015, the American Heart Association. C, Intravital microscopy of macrophages egressing the spleen after myocardial infarction. Reprinted from Swirski et al 15 29 Optoacoustic imaging combined with MRI has also been used to visualize cellular and biological processes in preclinical settings, often with only one or dual channels for imaging biological processes. 30 Optically visualized targets in mice can be translated toward clinical applications by switching from fluorescent beacons to PET isotopes. 31 Radioisotopes solve the problem of agent detection in deep tissues where microscopic resolution is insufficient. Several studies have shown the exquisite match between optical and radionuclide labels in interrelated systems.
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Hybrid PET/MRI
After the development of PET detectors that are functional in high magnetic fields, hybrid PET/MRI is a unique modality combination that has emerged in the last decade, as preclinical and clinical integrated systems have become available. 33 Initially, PET and MRI were combined to compare them, 34 but the combined modality has proved to be immensely useful. The technology combines PET's high sensitivity for radionuclide tracers that track biological processes with MRI's versatile applications and high resolution at any depth of practical interest. Different imaging techniques use different energy spectra to derive images. While optical imaging relies on detecting photons, MRI uses sound waves and PET uses γ-rays. The synergistic effect of combining PET and MRI has had numerous oncological, neurological, and cardiovascular applications over the past few years. 35 MRI has a wide range of preclinical and clinical applications in cardiovascular disease and beyond. In addition to excellent spatial resolution and soft tissue contrast for morphological information, MRI has the advantage of being able to visualize biological processes, molecular targets, and magnetic resonance (MR) reporter genes. When directed at organ systems that contain water molecules, MRI displays proton signals inside a strong magnetic field, processing after a radiofrequency pulse and forms images by either longitudinal and transverse relaxation times, T1 and T2/T2*. Although it most frequently uses water protons (1H), MRI can image other nuclei, including carbon-13 ( 13 C), fluorine-19 ( 19 F), and phosphorus-31 ( 31 P). Additional MRI advancements comprise T1ρ, arterial spin labeling, MR angiography, diffusion, hyperpolarized metabolic, and magnetization transfer imaging. 36, 37 In the brain, blood oxygenation level-dependent contrast studies, referred to as functional MRI (fMRI), are widely used to assess brain function. 38 Conventional contrast agents, such as gadolinium (Gd) chelates and ultrasmall iron oxide particles, alter T1 or T2/T2* relaxation of water protons, respectively, and can be used for molecular targeting. Multiple Gd chelates can be linked together via a targeted carrier, such as a nanoparticle, to amplify the signal and improve sensitivity. Other recently developed contrast agents include chemical exchange saturation transfer agents and 19F perfluorocarbon nanoparticles. 36 To obtain motion-artifact-free images of a pulsing vessel or beating heart, postprocessing, hardware advances, and improved image acquisition schemes have led to additional cardiovascular applications, including diffusion MRI tractography, 39 19F imaging, 40 contrastenhanced MRI, 41 and chemical exchange saturation transfer imaging. 42 PET is a radionuclide-based technique that detects pairs of γ-rays emitted by a positron-emitting radionuclide. PET is a commonly used translatable imaging technology sensitive to picomolar concentrations of biomarkers. PET tracers are labeled with positron-emitting radionuclides (eg, 11 C, 13 N, 15 O, 18 F, 64 Cu, 68 Ga, and 89 Zr) produced in a generator or cyclotron. These radionuclides can be incorporated into chemicals that are normally processed by the body, such as glucose, water, or ammonia, or into imaging agents that bind to receptors. Once injected, these radiotracers may report on specific biological processes. Although it entails radiation exposure, low spatial resolution, and the need for a generator or cyclotron to produce radionuclides, PET has tremendous potential for developing sensitive tracers that can target biological processes. The most frequently used radiotracer is 18 F-fluorodeoxyglucose (FDG) for glucose uptake. [43] [44] [45] [46] [47] [48] [49] [50] Examples of other PET tracers with potential relevance for cardiovascular imaging include 11 C-PK11195 for macrophage activity (and inflammation), 51 11 C-hydroxyephedrine PET for sympathetic innervation, 52-54 13 N-ammonia for blood flow, 47 18 F-sodium fluoride (NaF), 55 and 15 O-H 2 O for perfusion. [52] [53] [54] Attenuation in PET imaging happens when photons emitted by the radioisotope are absorbed by tissue before reaching the PET detector. Despite well-standardized attenuation correction for combined CT imaging, generating accurate attenuation corrections for MR-based approaches remains a challenge in PET/MRI. This remains particularly challenging for cardiac applications because of cardiac motion or in patients with implants. 35 Using PET/MRI to follow biomarkers provides opportunities for phenotyping, early diagnosis, and measuring therapeutic efficacy in cardiovascular disease. One advantage of PET/ MRI compared with PET/CT is the relatively low radiation dose, facilitating serial imaging or the use of multiple PET tracers. The second advantage of MRI over CT is its capability to provide detailed soft tissue contrast of the brain, carotids, and myocardium. Only for imaging of coronary arteries, MRI has limited robustness compared with CT. 35 MRI-based cardiac and respiratory motion correction can additionally enhance both MRI and PET image qualities, as well as PET-based quantification. 35 Both PET and MR reporter gene expression imaging are expanding and now have the potential to serially track cells, [56] [57] [58] especially with CRISPR/Cas9 gene editing rapidly gaining popularity. Hybrid PET/MRI can yield quantitative information on several biomarkers simultaneously, which is a unique advantage for a clinical modality. Theoretically, 2 or 3 molecular or cellular processes could be imaged in 1 setting, for instance by using molecular imaging agents labeled with 18 F (detected by PET), Gd, and 19 F (detected by MRI). Although small amounts of a biological marker can be traced with high sensitivity by PET, MRI can not only provide a high-resolution anatomic read out but also, after injection of Gd as an MR contrast agent, specifically follow enhancement of large vessels or infarcted regions. Furthermore, after injection of perfluorocarbon emulsions, MRI can use 19F to follow local inflammation with high specificity. 40 A hypothetical preclinical scenario of multiparametric PET/MRI combines specific MR reporter genes to track progenitor cells, diffusion MRI tractography to detail neuronal or myocardial microstructure, 39 and 11 C-PK11195 PET to Multiparametric Imaging of Organ System Interfaces image macrophages 51 in the infarct. By using 11 C-PK11195 PET to visualize the proportion of these cells differentiating toward activated macrophages and diffusion MRI tractography to determine how the inflammatory reaction affects vital connective networks, this approach could give insights on how progenitor cells are recruited to the ischemic region and how such an intervention influences tissue architecture.
Immune-Cardiovascular System Interactions
During acute cardiac disease, immune cells are recruited to either the atherogenic vascular regions in large vessels or the ischemic cardiac tissue. Multiparametric imaging can help uncover systemic interactions between the immune system and the cardiac or vascular tissues. The major hurdle for imaging large vessels and the heart is motion from a pulsing artery, a beating heart, or respiration. Cardiac contractions and artery pulsations are several orders of magnitude larger than cellular motion or molecular interactions, both of which can be followed by imaging. The technical challenge of correcting for respiratory or contractile motion means cardiovascular imaging applications have not advanced as much as neurological or oncological imaging applications, in which organ motion plays a lesser role. Nevertheless, various multichannel imaging studies, using optical applications and PET/MRI in preclinical and clinical settings, illustrate the interplay between inflammation and cardiovascular disease. More specifically, several studies seek to image immune cell interactions in atherosclerotic plaques and cardiac ischemia in connection with the hematopoietic system.
Vascular Inflammation
Because neither respiratory nor pulsatile motion affect it, the inflamed ear vasculature has been a straightforward model to follow movement and interaction of 3 cell types simultaneously: CX3CR1 GFP macrophages, LysM eGFP neutrophils, and NG2
DsRed pericytes around vessels. 59 Imaging showed increased intercellular adhesion molecule 1 (ICAM-1) expression by NG2
DsRed pericytes during innate immune responses. 59 The inferior vena cava's large size and minimal pulsatile motion make it well suited to intravital 2-photon microscopy, which was used to image the recruitment of adherent platelets (CD41) and neutrophils (LysM eGFP ) to the blood vessel wall (second harmonic generation) in a deep venous thrombosis model. 60 Furthermore, correcting for respiratory and pulsatile arterial motion in atherosclerosis-prone large arteries has allowed leukocyte accumulation to be visualized at subcellular resolution. 61 Using intravital imaging, different inflammatory leukocyte subsets within the carotid arteries of athero-susceptible mice have been identified in vivo. As a proof of concept, vascular cell adhesion molecule 1 (VCAM-1), myeloid cell polarization detector CD62L, and platelet marker CD41 were imaged in relation to leukocyte interactions. Also, distinct leukocyte subset behaviors were simultaneously imaged with genetically altered athero-prone mice that express GFP in leukocytes and with labeled antibodies against CD4, CD8, and Ly6G to identify different subsets recruited to the carotid bifurcation. This approach revealed increased numbers of rolling neutrophils over time. This rolling behavior was not observed in monocytes, thereby pointing out different recruitment kinetics for myeloid subsets. 61 YFP macrophages exhibited dancing on the spot behavior with extending and contracting cell processes, and CD11c YFP dendritic cells migrated within intimal plaque in athero-prone segments of the murine carotid artery ( Figure 2D) . 20 In the future, these imaging techniques, which suppress motion artifacts, will provide a platform to follow the early molecular and cellular interactions that cause atherosclerotic events within the arterial wall.
Multichannel vascular imaging can also be achieved by hybrid PET/MRI. The main advantage of using PET/MRI is that MRI's enhanced soft tissue contrast, compared with CT, can easily delineate the outer vessel wall. [62] [63] [64] Structural MRI combined with 18 F-FDG PET has identified and characterized vascular inflammation in the carotid artery by glucose uptake into macrophages in atherosclerotic 62 and athero-prone 63, 64 vessels. A preclinical dual PET/MR fibrin imaging probe combined PET's sensitivity with MRI's high spatial resolution using a Gd-based fibrin-targeted EP-2104R with partial exchange of Gd for copper 64 ( 64 Cu) to simultaneously image a rat arterial thrombus model of the carotid artery. This combination provided a continuum of detectability between the lowest concentration of tracer, as detected with PET, up to a high concentration and accurate localization of tracer, visualized by MRI. Furthermore, MRI could accurately identify vessel walls by MR angiography, whereas fibrin was present at adequate concentrations in many clots for MR detection using T1-weighted molecular imaging of the Gd-based probe. PET's higher sensitivity could be beneficial for fresh or small clots. This is a synergistic example of how dual-modality molecular probes can boost diagnostic confidence since artifacts diverge between modalities. Moreover, dual imaging may eliminate the need for a preinjection baseline MR examination because colocalizing the PET signal would confirm the probe presence. 65 Although vessel wall MRI has better soft tissue contrast, CT imaging can easily delineate areas of macrocalcification within blood vessels. Combined vascular CT with 18 F-NaF PET for microcalcification can noninvasively detect a range of calcification sizes in active unstable atherosclerosis. 55 Vascular calcification is highly associated with high-risk patients. 55 Research on vascular mineralization will benefit from noninvasive imaging studies at a systems level, elucidating the systems link between the phenotype of bone marrow-derived immune cells on the one hand and vascular mineralization on the other hand. As the field of vascular imaging expands and technologies for motion-artifact-free images become available, many questions about the pathogenesis of atherosclerosis remain to be answered. Which endothelial events initiate plaque development? Which combination of biomarkers can reveal interactions in time and space during the development of vulnerable atherosclerotic plaques? One option for future multichannel large-vessel imaging could be VCAM-1 detection by MRI, 66 combined with MR angiography, immune cell tracking, and 64 Cu fibrin PET. 65 Imaging Multiparametric Imaging of Organ System Interfaces interactions could report on immune cell VCAM-1 adhesion to the walls of large vessels, 64 Cu fibrin PET could visualize activation of clotting in these vessels, and MR angiography could image vessel walls at high resolution.
Cardiac Inflammation
Cardiac and respiratory tissue motion reduces spatial and temporal imaging resolution during cardiac intravital microscopy. Recent advances that combine thoracic surgery, tissue stabilizers, and acquisition gating methods have enabled single-cell resolution imaging in the beating mouse heart (Figure 2A) . 19 ,67 C57BL/6 hearts heterotopically transplanted into LysM GFP mice or orthotopic native LysM GFP hearts have been imaged by 2-channel intravital microscopy. To reduce tissue motion, cardiac tissue was stabilized, and Z-stack acquisition was synchronized with heart rate. Time-lapse imaging revealed LysM GFP neutrophils recruiting and firmly adhering to the coronary endothelium and extravasating from coronary veins (labeled with nontargeted Q-dots). Neutrophils then infiltrated the myocardium and eventually formed large cell clusters. Similarly, time-lapse imaging also visualized neutrophil adherence to endothelium and extravasation by grafting mutant hearts for ICAM-1 (important for neutrophil recruitment), Mac-1 (a receptor for ICAM-1), and LFA-1 (lymphocyte function-associated antigen 1; another ICAM-1 binding integrin). 67 Also endoscopic time-lapse imaging of the heart has shown CX3CR1 GFP monocytes patrolling in cardiac vessels and infiltrating after acute infarction 68 (Movies I and II in the Data Supplement). More recently, cardiac optogenetics has been used to investigate cardiac pacing and resynchronization via channelrhodopsin transgene at ventricular sites in rats. 25 This technique will enable future studies to map functional myocardial organization and cardiac pacing.
Combined optical FMT and MRI has noninvasively imaged myocardial macrophage infiltration post-myocardial infarction (MI) in mice with dual-labeled magnetofluorescent CLIO-Cy5.5 nanoparticles taken up by macrophages. 69 Furthermore, multispectral FMT/CT combined with serial MRI has explored monocyte and macrophage source, tissue kinetics, and clearance post-MI during post-MI cardiac wound healing in splenectomized and nonsplenectomized mice. 70 More specifically, FMT imaging combined with anatomic CT tracked 3 interconnected healing biomarkers: myeloid cells with CLIO-633, proteolysis with ProSense-750, and angiogenesis with IntegriSense-800. Splenectomized mice showed fewer accumulated myeloid cells, which produce proteases and enhance angiogenesis. Accordingly, serial cardiac MRI detected an adverse left ventricular function outcome. These imaging data confirmed the role of the spleen in myocardial healing post-MI. 70 Combined 18 F-FDG PET and late Gd enhancement (LGE) MRI has been used to explore post-MI inflammation in mice and patients, revealing high 18 F-FDG uptake by inflammation after MI. A few post-MI cardiac studies have used PET with LGE) by MRI to colocalize viable and metabolically active cells'
18 F-FDG uptake to the increased extracellular space associated with scar tissue. In addition, a preclinical study verified 18 F-FDG activity in infarct myeloid cells. 44 Yet, 18 F-FDG is not specific for inflammatory cell activity in the heart, as it also acutely delineates glucose utilization in dysfunctional but viable cardiomyocytes after MI. Combining 18 F-FDG PET with LGE MRI, both methods were used after acute myocardial infarction to evaluate improved LV function in patients early and again 6 months later. PET measured regional FDG uptake, whereas LGE MRI measured scar transmurality. The simultaneous assessment of FDG PET and LGE MRI, using a hybrid PET/MRI system, more accurately predicted the regional outcome of wall motion acutely after MI. In a small proportion of segments with discrepant FDG PET and LGE MRI findings, FDG uptake was a better predictor of functional recovery in patients. 71 The confounding uptake of 18 F-FDG in high-metabolism cells, such as myocardial and skeletal muscle, hampers accurate quantification of inflammation. To address this, new molecular imaging agents that specifically target activated inflammatory cells in the postischemic myocardium are being developed. For example, the CXCR4 receptor is a potential molecular target for multiparametric imaging to identify activated inflammatory cells in human postischemic myocardium. The CXCR4 receptor is highly expressed by leukocytes that infiltrate inflamed tissues. A PET ligand for CXCR4, 68 Ga-pentixafor, has been imaged with simultaneous LGE MRI for scar size and a near-simultaneous Tc-99m sestamibi single-photon emission computed tomographic scan for perfusion on day 3 after MI. The LGE transmural scar tissue revealed no perfusion by single-photon emission computed tomography. PET images showed high 68Ga-pentixafor signal for CXCR4 expression in the LGE infarct area, thereby indicating active inflammatory processes at the site of underperfused infarcting myocardium. 72 Combined optical and PET/MRI of macrophages after MI quantified tissue macrophages noninvasively using fluorescently labeled VT680 and 18 F-labeled Macroflor. The affinity of Macroflor, a modified polyglucose nanoparticle, to macrophages was examined by time-lapse optical imaging. Intravital microscopy displayed extravasation and cellular uptake kinetics in CX3CR1 GFP reporter mice: 30 minutes after injection, Macroflor nanoparticles cleared from the blood stream and colocalized with CX3CR1 GFP macrophages in the myocardium ( Figure 3A and 3B) . 32 The optical timelapse data on uptake by macrophages revealed that these nanoparticles were ingested by macrophages within a time frame that enables PET imaging with the short isotope halflife of 18 F (≈110 minutes). Consequently, 18 F-Macroflor PET imaging was established in mice and rabbits to report on macrophages in ischemic heart disease and atherosclerosis. Dual-target PET/MRI provided macrophage quantification by 18 F-Macroflor PET combined with molecular MR sensing of myeloperoxidase, an enzyme produced by inflammatory macrophages, at 2 time points after MI. The 18 F-Macroflor signal indicated slightly more macrophages at the resolution phase of infarct healing on day 6 post-MI compared with the inflammatory phase at day 2 after MI. The simultaneously measured myeloperoxidase MR signal decreased from day 2 to day 6 post-MI, which is consistent with inflammation resolution. Conversely, ApoE −/− mice after MI showed increased atherotic plaque signal in both channels, thereby identifying disease-promoting inflammation post-MI. Thus, these 2 imaging biomarkers could identify macrophage number (by Macroflor PET) and phenotype (by myeloperoxidase MRI) to uniquely differentiate between increasing and resolving inflammation (Figure 3C through 3E; Movie III in the Data Supplement). 32 Autonomous innervation of the heart is typically followed noninvasively using a PET tracer, as sympathetic denervation occurs in the infarcted myocardium. 73 Multichannel imaging that tracks biomarkers for autonomous nervous interactions, perfusion, and inflammatory players in cardiovascular disease could be instructive for understanding disease progression. Two recent studies combined 3 biomarkers: LGE MRI for function and scar size, 15 O-H 2 O for perfusion, and 11 C-hydroxyephedrine PET for sympathetic innervation in patients. Myocardial blood flow and sympathetic innervation in noninfarcted remote myocardium was linked with cardiomyopathy. 54, 74 High 11 C-hydroxyephedrine, a signal of sympathetic myocardial innervation, was strongly related to hyperemic perfusion and contractile function in the remote myocardium of infarcted hearts. 74 Low 11 C-hydroxyephedrine, a signal of defects in sympathetic innervation, correlated with total scar size on LGE-MRI but did not correlate with the perfusion defects. The 15 O-H 2 O perfusion defects appeared smaller than the 11 C-hydroxyephedrine innervation defects.
These findings shed light on pathophysiological processes in heterogeneous scars. 54 Stress, related to the proliferation and release of hematopoietic progenitor cells, can also affect sympathetic innervation in cardiovascular disease, as will be discussed below.
Going forward, multiparametric optical and PET/MRI combinations may synergistically elucidate the pathophysiology of local, systemic, and remote inflammation during cardiovascular disease. Putative examples of interesting multiparametric strategies include the combined water diffusion imaging for cardiomyocyte fiber tracking, cardiac 19 F MRI for macrophages with CXCR4 PET imaging by 68 Ga-pentixafor for activated inflammatory cells or PET using 11 C-hydroxyephedrine to detect sympathetic innervation. These multichannel approaches could also enhance understanding of separate imaging technologies' specificity. More importantly, these combined techniques can report on early biomarker interactions among the pathophysiological processes that lead to heart failure; such information can then be used to predict disease, therapeutically intervene and monitor disease progression. For example, imaging could reveal post-MI interaction between cytokines and inflammatory cells that orchestrate pathogenic changes, such as rearranging myocardial fibers. 
Nervous System Interactions
After stroke, microglia are activated, and circulating immune cells migrate to the ischemic region. Neurons in the affected area die, resulting in temporary or permanent neurological deficits. Inflammatory processes and neuronal (dys)function after stroke can be mapped using multichannel imaging. Imaging nervous systems interactions can highlight this vital system's responses in cardiovascular disease. First, we will review imaging applications that focus on post-stroke inflammatory interactions and subsequent connectivity loss between neurons. We will then review relevant optical and PET/MRI applications for the central nervous system with a focus on potential markers for imaging immune interactions and nervous connectivity after stroke. Studies that address nervous system interconnections with the hematopoietic system will be described in a later section on hematopoietic system interactions.
Central Nervous System Interactions
Intravital 2-photon imaging of blood vessels using fluorescent dextran has visualized endothelial integrity after stroke.
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The microscope's lasers have also been applied to the rat cortex to occlude one specific vascular lumen in the presence of a circulating photosensitizer, thereby illustrating how single microinfarcts in a cortical column can cause debilitated performance on a whisker-based behavioral task. 78 Furthermore, the distinct proliferative response of CX3CR1 GFP microglia as both resident brain macrophages and infiltrating brain CX3CR1 GFP leukocytes has been mapped optically showing 2 discrete cell populations with different functions. 79 Longitudinal in vivo 2-photon microscopy investigating the role of fractalkine and its receptor CX3CR1 in leukocytes after ischemia has revealed that CX3CR1 deficiency induced an early protective inflammatory environment. 80 Intravital 2-photon microscopy has also revealed that diabetes mellitus disturbs cerebral capillary blood flow after stroke. 81 Recent in vivo 2-photon calcium imaging suggested that microglia are vital to the response after stroke, in that they protect against brain injury by stabilizing neuronal networks. Imaging CX3CR1 GFP mice after cerebral ischemia showed microglial process extension to neurons with increasing intracellular RCaMP1 calcium levels, whereas decreasing neuronal RCaMP1 signal was associated with microglial process withdrawal. 82 After stroke, 2-photon microscopy revealed elevated synaptogenesis rates within recovering peri-infarct tissues. 76 Optogenetics has been used to map widespread motor output deficits produced by ministrokes 83 and to promote functional recovery by precisely stimulating neurons to boost their activation in the peri-infarct area. 84 In addition, functional connectivity optical intrinsic signal imaging has sensitively tracked functional connectivity in the murine stroke model. 85 The potential of multichannel optical imaging in understanding stroke can be seen via other relevant disease models. First, intravital 2-photon imaging of neuroinflammation in experimental autoimmune encephalomyelitis elucidated perivascular lymphocyte movement of CD4 + T-cell subsets 86 and CD11c + cells 87 near vessels of the central nervous system. Second, intravital microscopy in a spinal injury model highlighted the role of Nr4a1, a regulator of macrophage catecholamine production, in leukocytes infiltration during disease exacerbation. More specifically, intravital microscopy reported on the inflammatory recruitment of immune cells after spinal injury by transferred 2D2-DsRed T cells into Nr4a1
GFP reporter mice and CX3CR1 GFP Nr4a1 −/− mice. 88 Although these cerebral inflammatory processes are not directly associated with cardiovascular disease, they illustrate that optical imaging neuroinflammation might provide insight into the processes after stroke. For instance, macrophages may use the perivascular area as highways to get to the ischemic area after stroke. Furthermore, macrophage catecholamine production may occur in these perivascular regions. Moreover, the Brainbow toolbox, which can map neuronal circuits on a large scale, as described above, 21 may also be applied to stroke. Examples of Brainbow technologies unconnected to cardiovascular disease include imaging mouse cerebellum Purkinje cells in multiple colors 89 or pyramidal neurons in the cortex during development. 90 The Brainbow system's ability to label uniquely many individual cells within a population could shed light on local and remote neuronal injury after stroke. Other recent imaging advances that could be used in stroke research include opto-fMRI, in which optically driven stimulation is assessed by blood oxygenation level-dependent response at the stimulated site in mice using fMRI. 91, 92 Recent multiparametric PET/MRI stroke studies have already shown this imaging modality's potential. Namely, a preclinical study has combined phagocytosed ultrasmall iron oxide particles detected by T2* MRI with 11 C-PK11195 PET for microglia activation to quantify phagocytic activity to observe poststroke inflammatory processes longitudinally and predict long-term tissue fate. 51 Case reports on an ovine stroke model and stroke patients showed that simultaneous 15 O-H 2 O PET/perfusion MRI could more accurately map hypoperfused tissue with diffusion-weighted and T2-weighted MRI for outcome. 53 More recently, multiparametric 18 F-FDG PET and MRI visualized the inflammatory activity for atherosclerotic lesion detection in patients after ischemic stroke. 45 By detecting biological features of high-risk plaques, 18 F-FDG PET/ MR angiography in nonstenotic atherosclerotic plaques ipsilateral to the stroke suggested that these plaques have a causal role in stroke. 45 Applicable multiparametric PET/MRI combinations in central nervous system disease models may shape future stroke research. For example, a study in which 18 F-FDG PET recorded metabolic brain activity while blood oxygenation level-dependent-fMRI simultaneously mapped vascular and oxygenation changes of the rat brain, at rest and during activation by whisker stimulation, found spatial and quantitative discrepancies between the PET and the fMRI activation data. The blood oxygenation level-dependent-fMRI approach imaged primarily the higher-order somatosensory network, whereas the PET method identified regions, such as the insula, the thalamus, or the amygdala, that are known to be involved in pain processing and emotion. These results reveal comprehensive and complementary information that can further decode brain function and brain networks. 93 Relatedly, simultaneous PET/fMRI has been used to investigate the relationship between neurovascular responses and Multiparametric Imaging of Organ System Interfaces D2/D3 dopamine receptor occupancies in nonhuman primates. As D2/D3R antagonist doses increased, the reduction in D2/D3 dopamine receptor antagonist 11 C-raclopride on PET correlated with increased cerebral blood volume shown by fMRI. These data suggest that vascular responses to D2R-like antagonists are coupled to changes in neuroreceptor occupancy. 94 The direct comparison of changes in neuroreceptor occupancy, shown by PET, with a simultaneously induced functional response, shown by MRI, has a variety of applications. For example, 2 mouse models of Alzheimer disease have been longitudinally imaged via PET/MRI to assess 4 biomarkers, namely (1) β-amyloid deposition using 11 C-Pittsburgh compound B PET, (2) disease-related regional cerebral blood flow by arterial spin labeling-MRI and 15 O-H 2 O PET, (3) microhemorrhages by gradient MRI, and (4) synaptically driven network activity using 2-photon calcium imaging. Loss of perfusion correlated with the growth of β-amyloid plaque burden but was not related to the number of microhemorrhages induced by cerebral β-amyloid angiopathy in these models. Subsequent 2-photon calcium imaging revealed similar neuronal hyperactivity. 52 Another PET/ MRI study of the nervous system followed elevated brain levels of translocator protein, a marker of glial activation, to track increased neuroinflammation in patients with chronic low back pain. 95 Finally, simultaneous PET/MRI has identified a novel biomarker for measuring effective connectivity in the resting human brain with open and closed eyes. Metabolic connectivity mapping calculated the spatial correlation between voxel functional connectivity, from fMRI, and local postsynaptical energy metabolism, by 18 F-FDG PET at the target region. Signaling hierarchies in the brain and their defects in brain disorders can be studied with this biomarker of neuronal energy metabolism. 46 These types of multiparametric imaging studies of connectivity and inflammation in the central nervous system could be extrapolated to cardiovascular organs and more specifically to stroke research. For example, glial activation by translocator protein PET 95 could be combined with diffusion tensor MRI for tracking fibers, fMRI for neuronal activation, and arterial spin labeling-MRI for cerebral blood flow. Such modalities could visualize the effect of glial activation on cerebral blood flow and neuronal fiber integrity and connectivity after stroke.
Hematopoietic System Interactions
The hematopoietic system consists of the blood-producing organs, like the bone marrow, and closes the circuit connecting multiple organs by producing circulating cells. During cardiovascular disease, leukocytes leave the bone marrow and spleen and move to the inflamed tissue. 70 To keep up with demand, cell production increases in the spleen and bone marrow. 5, 15, 96, 97 The local splenic environment orchestrates emergency leukocyte production after MI, 70, 96 whereas bone marrow niche cells provide signals to regulate HSC proliferation and leukocyte production after MI 97 or stroke. 5 Newly produced immune cells exit hematopoietic systems to infiltrate system-wide the activated endothelium of atherosclerotic plaques, 96 the infarcted myocardium, 97 or the infarcted brain. 5 To attain a system-wide perspective on cardiovascular disease, imaging studies should include hematopoietic organs that supply immune cells for crucial inflammatory processes during cardiovascular disease.
The spleen and HSC niches in the bone marrow have been longitudinally imaged to understand the complex biological response after MI. 15, 96 Intravital 2-channel imaging followed the departure of CX3CR1 GFP macrophages from the splenic subcapsular red pulp into the blood in CX3CR1 GFP mice after MI. Splenic monocytes departed in large numbers from the spleen, accumulated at the infarct, and engaged in wound healing ( Figure 2C ; Movie IV in the Data Supplement). 15 Multimarker imaging of myocardial healing after MI has underlined the importance of extramedullary monocytopoiesis at the spleen, as discussed above. 70 For in vivo longitudinal visualization of the HSC niche, 10, 11 HSCs underwent fluorescence-activated cell sorting, were labeled with DiD (1,1′-dioctadecyl-3,3,3′,3′-tetramethylindodicarbocyanine perchlorate), and, after adoptive transfer, were followed by serial intravital microscopy, which showed that transferred HSCs settled into the bone marrow before MI and were released after MI. The relocation of HSCs to the spleen after MI was consequently investigated by labeling these cells with a photoconvertible dye. First, photoconversion through laser illumination occurred in the skull bone marrow, where cells engrafted after adoptive transfer. After MI, the cells, which had been previously tagged by photoconversion in the marrow, were detected in splenic cell suspensions, thus indicating progenitor traffic from the marrow to the spleen. 96 Circulating immune cells are crucial in the pathogenesis of stroke, and their production in the hematopoietic niche has been imaged longitudinally using multichannel optical imaging after stroke. Sorted HSCs labeled with DiD before adoptive transfer were longitudinally followed before and after stroke ( Figure 2B ). 5 Serial in vivo bioluminescence reporter gene imaging of mitosis-luciferase mice after stroke additionally revealed that bone marrow cell cycling peaked 4 days after stroke. These results demonstrate that stroke boosts HSC proliferation and causes increased monocyte supply. 5 To examine the effect of psychosocial stress on the immune system, DiD-labeled HSCs, together with fluorescently labeled dextran to identify blood vessels and OsteoSense to delineate the bone marrow niche, were followed before and at 7 days after stress exposure. Longitudinal intravital microscopy at the calvaria showed accelerated dilution of the membrane dye, which indicated increased proliferation of these labeled cells, in mice exposed to stress. Higher HSC proliferation gave rise to higher levels of disease-promoting inflammatory leukocytes and promoted plaque features associated with vulnerable lesions that cause MI and stroke in humans. 98 Together, these data provide insight into regulation of hematopoiesis modulating leukocyte output in cardiovascular disease.
Bone marrow HSCs give rise to myeloid cells, including monocytes, macrophages, neutrophils and dendritic cells, and lymphoid cells, like T cells and B cells. To explore the clonality of heterogeneous HSCs in the bone marrow, fluorescent hematopoietic cell labeling was assessed by crossing the polyinosine-polycytidine-inducible Mx1-Cre with HUe (Mx1-Cre;HUe), a process similar to the Brainbow system used in the brain. 22 When the Mx1-Cre;HUe mouse were given a polyinosine-polycytidine pulse, multicolored hematopoietic Multiparametric Imaging of Organ System Interfaces cells within the calvarial cavity could be visualized using intravital microscopy. These clonal populations were further analyzed using fluorescence-activated cell sorting to identify endogenous HUe fluorescence from separate clonal populations and categorize them by cell type (eg, monocyte, B cell, T cell). Furthermore, these functional populations were coupled with analyses of gene expression and chromatin state at clonal resolution. HSC function appeared to be bound by cell-autonomous epigenetic constraints. 22 Follow-up on separate clonal HSC populations, for example, to track clonal myeloid cell expansion after ischemic injury, would also be an interesting approach to studying cardiovascular inflammation.
Whole-body 18 F-FDG PET/CT of patients with coronary artery disease has shown increased inflammatory activity in the carotid artery that correlated with increased activation of both the spleen and the lumbar vertebrae bone marrow. The 18 F-FDG metabolic activity of carotid artery, bone marrow, and spleen was highest in patients with acute MI, intermediate in patients with angina, and lowest in control subjects. 49 Multiparametric multiorgan information on infarct healing has been provided by 18 F-FDG PET combined with MRI on the heart, spleen, and bone marrow to characterize the inflammatory response to acute MI in patients (Figure 4) . 47 Cardiac MRI using LGE for infarct size and T2 for edema showed regional edema exceeding the area of LGE. In patients with acute MI, after fasting and heparin suppressed myocardial uptake, PET detected inflammatory FDG uptake in the infarct region at the area of the 13 N-ammonia-outlined perfusion defect. 18 F-FDG PET of the spleen and bone marrow suggested that these organ systems are the birthplace of inflammatory cells, as the metabolic rate in the infarct correlated with metabolic rates of remote myocardium, spleen, and bone marrow but not with muscle or liver (Figure 4) . 47 In mice, rabbits, and patients with atherosclerosis, 18 F-fluorothymidine (FLT) PET has been used as a biomarker for cell proliferation in plaques and hematopoietic activity in bone marrow ( Figure 5 ). 48 −/− hearts displayed compromised tissue healing, as indicated by decreased protease activity shown by FMT/CT and post-MI heart failure imaged by functional cardiac MRI. 97 Multiorgan PET/CT has explored whether resting amygdalae activity, which is prompted by stress, is associated with subsequent cardiovascular events in patients. This prototype study interrelated the nervous system, immune interactions in the cardiovascular system, and the hematopoietic system. 18 F-FDG PET/CT imaging was applied to three regions simultaneously to quantify regional brain metabolism (ie, amygdalar activity), hematopoietic tissue activity in the bone marrow, and large-vessel arterial plaque inflammation. Increased . A, Representative multiparametric cardiac magnetic resonance (CMR) and PET images in a patient early after MI and reperfusion. The anteroseptal infarct region is highlighted by gadolinium contrast late enhancement (Gd LE; top row) and shows transmural tissue damage (bright) and subendocardial no reflow (black). Transmural edema (bright) on T2-weighted images (second row) exceeded the LE area. PET perfusion images (third row) showed perfusion defects in the infarct area with LE (late Gd enhanced). Also, 18 F-deoxyglucose (FDG) uptake is present in the infarct region even when myocyte uptake is suppressed by heparin, a result that is consistent with regional inflammation (bottom row). B, Multiorgan PET-computed tomographic (CT) analysis of glucose utilization. PET images (right) and hybrid PET/CT images (left) of the cardiac region show the positioning of regions of interest for quantitative analysis of glucose use in the heart and lymphoid tissue. Reprinted from Wollenweber et al 47 with permission of the publisher. Copyright ©2014, Wolters Kluwer Health, Inc. Multiparametric Imaging of Organ System Interfaces wall (aorta) linked brain activity to subsequent cardiovascular disease through increased bone marrow activity and arterial inflammation. Emotional stress correlated with increased cardiovascular disease risk ( Figure 6 ). 99 We think these multiorgan studies will progress toward PET/MRI and thus incorporate several imaging reporters for distinct biological processes. For instance, fMRI for brain activity and cardiovascular Gd-enhanced MRI could be combined with 18 F-FLT PET to track cell proliferation in different systems or to assess glial activation in the brain by translocator protein imaging. 95 These system-wide multiparametric studies are the direction in which cardiovascular imaging ought to progress because they provide unique information on complex disease processes in humans.
Challenges and Future Directions
Multiorgan multiparametric imaging will dynamically show when and where genetically and biochemically defined molecules, signals, and processes appear, interact, and disappear. Well-thought-out study designs with proper randomization are crucial to investigate causality of correlating imaging biomarkers. Going forward, the challenge will be to integrate all important inputs and visualize the cellular and subcellular interactions in disease development while muting less relevant information. Optical intravital and PET/MR imaging acquire large amounts of data on molecular and cellular processes, such as migration or cell-cell interaction. These processes can be quantified to reveal interactions among stromal and inflammatory cells, such as monocytes and macrophages; leukocyte production in the bone marrow; the vasculature; large vessels; and target organs such as the heart and brain.
One of the challenges in collecting multiplex data sets is quantifying and integrating these data. Although existing algorithms and statistical methods may be adequate for processing and analyzing a single data stream, generating large data sets requires innovation. Standardization is a prerequisite when comparing information acquired from different modalities using different tracers. Coupling imaging with relevant genetic data would further enrich output. One research area pushing forward into these possibilities is human neuroimaging, which has already been called a big data science. 100 For example, The ENIGMA (Enhancing Neuroimaging Genetics F-FDG and 18 F-FLT images show PET tracer uptake in the vessel wall of the aortic arch (arrows). Reprinted from Ye et al 48 with permission of the publisher. Copyright ©2015, the American Heart Association. Multiparametric Imaging of Organ System Interfaces through Meta-Analysis; enigma.loni.ucla.edu) platform has brought together researchers in neuroimaging and genetics to study brain structure and function using MRI, DTI, fMRI, and genome-wide association study data. 100 Another example is systems biology frameworks that have been developed for archiving and mining data. 101 Discriminating decisive biomarker interactions in these large data sets might provide clues about underlying biological mechanisms and thus pave the way for discovery-oriented cardiovascular science. The terabytes of data will supply input for pattern-seeking and other algorithms 100 that can help decipher complex pathophysiological processes in cardiovascular disease.
Conclusions
We have sought here to explain, illustrate, and extend multichannel imaging technologies on a systems level for translatable cardiovascular imaging research. Advances in multicolor intravital microscopy and multichannel PET/MRI help visualizing the molecular and cellular interactions that alter living cells and organ systems in cardiovascular disease. Further technical refinement of these technologies will likely occur in the foreseeable future, continuing the progress of the last decade.
Motion-corrected multiparametric imaging of the heart and large vessels has uncovered specific immune cell functions and their actions, including neutrophils, monocytes, and macrophages. Similarly, nervous and hematopoietic system interactions were mapped via multichannel imaging of specific biomarker selections. Multibiomarker information may give new systems insights on disease pathophysiology and act as a predictive tool for cardiovascular disease. Looking ahead, we envision that imaging research will discover informative disease biomarker combinations which provide insight into the dynamic spatial, molecular, and cellular aspects of cardiovascular disease. For clinical practice, such data may be harnessed to identify patients at high risk for cardiovascular events and then direct their therapies toward improved prevention. Figure 6 . Emotional stress, measured by the metabolic rate of resting amygdalae activity, predicted cardiovascular events. Increased 18 F-fluorodeoxyglucose (FDG) uptake in the amygdala, bone marrow, and arterial wall (aorta) in a subject who experienced an ischemic stroke during the follow-up period (right) vs a subject who did not (left). CVD indicates cardiovascular disease; SUV, standard uptake value; and TBR, target-to-background ratio. Reprinted from Tawakol et al 99 with permission of the publisher. Copyright ©2017, Elsevier Limited.
